Besides, COL11A1 expression has been suggested as a promising marker for invasive breast lesions (Freire et al., 2014) and ovarian cancer and has a positive correlation with cisplatin treatment (Rada et al., 2018). Here, COL11A1 is linked to ovarian cancer.